Koss-Olinger Consulting’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426K | Sell |
957
-41
| -4% | -$18.3K | 0.04% | 226 |
|
|
2025
Q1 | $484K | Buy |
+998
| New | +$484K | 0.04% | 206 |
|
|
2024
Q4 | – | Sell |
-896
| Closed | -$417K | – | 290 |
|
|
2024
Q3 | $417K | Buy |
896
+35
| +4% | +$16.3K | 0.04% | 183 |
|
|
2024
Q2 | $404K | Buy |
+861
| New | +$404K | 0.04% | 176 |
|
|
2024
Q1 | – | Sell |
-3,512
| Closed | -$1.43M | – | 310 |
|
|
2023
Q4 | $1.43M | Sell |
3,512
-393
| -10% | -$160K | 0.14% | 83 |
|
|
2023
Q3 | $1.36M | Sell |
3,905
-68
| -2% | -$23.6K | 0.2% | 65 |
|
|
2023
Q2 | $1.4M | Hold |
3,973
| – | – | 0.16% | 70 |
|
|
2023
Q1 | $1.25M | Buy |
3,973
+51
| +1% | +$16.1K | 0.16% | 74 |
|
|
2022
Q4 | $1.13M | Sell |
3,922
-2,931
| -43% | -$847K | 0.16% | 77 |
|
|
2022
Q3 | $1.98M | Sell |
6,853
-149
| -2% | -$43.1K | 0.34% | 25 |
|
|
2022
Q2 | $1.97M | Sell |
7,002
-1,346
| -16% | -$379K | 0.36% | 23 |
|
|
2022
Q1 | $2.18M | Buy |
8,348
+228
| +3% | +$59.5K | 0.35% | 24 |
|
|
2021
Q4 | $1.78M | Buy |
8,120
+4,355
| +116% | +$956K | 0.27% | 28 |
|
|
2021
Q3 | $683K | Buy |
+3,765
| New | +$683K | 0.11% | 91 |
|